Authors


Maureen Hennessey, PHD, CPCC, CPHQ

Latest:

The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple Aim

Infectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.



Maryann Webb

Latest:

Advocating for Better Regulatory Rules and Standard of Care for C difficile

Maryann Webb’s harrowing, personal experience with C diff, along with her professional work with federal agencies has prepared her for a life in advocacy with the Peggy Lillis Foundation. She wants to see the fecal microbiota transplant become more accessible and is working with Congress to make the infection a notifiable infectious disease.


Sara Rendell, PHD

Latest:

Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to Miss

Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.


Ellora Karmarkar, MD, MSc

Latest:

Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.


Teena Chopra, MD, MPH

Latest:

Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile Infections

To close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.


Nikita Jaggernauth, MD

Latest:

Tuberculosis Meningitis in an Immunocompetent Patient

Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.


Sunish Shah, PharmD, BCIDP

Latest:

An Overview of Cefiderocol Resistance Among Clinical Pathogens

Here is a review the mechanisms that lead to resistance, including risk factors.



Michael McAlister, PharmD, BCIDP

Latest:

STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis

New therapeutics offer some hope in this emerging market.


Jennifer Ronholm, PhD

Latest:

Agriculture and Antibiotics: Trying to Protect the Former and Preserve the Latter

Jennifer Ronholm, PhD, discusses the novel concept of microbiome protection to create healthier animals and reduce antimicrobial usage.



Rebecca Leach, MPH, BSN, RN, CIC

Latest:

Health Equity and the Impact on Infectious Disease

Inequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.


James A. McKinnell, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Christina H. Mallarino-Haeger, MD

Latest:

Fever of Unknown Origin: What Do We Know and Where Do We Go?

As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.


Geno Tai, MD

Latest:

The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic Arthritis

A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.


Kimberly O'Neil, PharmD

Latest:

Multidrug Resistance in a Patient With HIV

In this case study, clinicians review a challenging case.


Matthew Lengel, PharmD, MS, BCACP, AAHIVP

Latest:

340B Drug Pricing Program: What Is It and Why Is It Important?

The 340B program has had a great impact on access to HIV treatment and prevention services in the US.


Arturo Casadevall, MD, PHD

Latest:

COVID-19 Convalescent Plasma: What Is Its Role in Therapy?

The key is using the right dose on the right patient at the right time.


Jeanine Thomas

Latest:

Bringing MRSA Back to the Forefront

Jeanine Thomas, president and founder of MRSA Survivors Network, talks about her personal battle with osteomyelitis, her work as an advocate, and the need for data and awareness to bring it to the forefront again.


Molly Tucker, MD

Latest:

A Rare Case of Positive Heterophile Antibody in a Patient With West Nile Virus

This unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.


Peter Salgo, MD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Naeem Ur Rehman, PhD

Latest:

Considerations for Antimicrobial Stewardship While Optimizing Therapy for a Patient With HIV

Here is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.


Daniel R. Kuritzkes, MD

Latest:

High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.


Amanda Jezek

Latest:

An Update on the Pasteur Act

Amanda Jezek, of the Infectious Diseases Society of America (IDSA), offers some insight on the prospective bill in Congress, as well as other AMR initiatives the organization is involved in.


Abi Bautista-Alejandre

Latest:

Case of Rabbit Fever Diagnosed in US

The first 2024 case of tularemia also known as rabbit fever was confirmed in a Wheat Ridge, Colorado resident.


Elizabeth Braden, MD

Latest:

Tuberculosis Meningitis in an Immunocompetent Patient

Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.



M. Gabriela Cabanilla, PharmD, PhC

Latest:

I Kidney Not: Antibiotic Dosing Strategies in Intermittent Hemodialysis

In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.


Cristian Flores

Latest:

Resolution of Scurvy in a Patient With a Spinal Cord Injury

At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.

© 2024 MJH Life Sciences

All rights reserved.